0001140361-16-066225.txt : 20160519 0001140361-16-066225.hdr.sgml : 20160519 20160519130148 ACCESSION NUMBER: 0001140361-16-066225 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 GROUP MEMBERS: IZOR LLC GROUP MEMBERS: ROSALIND DAVIDOWITZ SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENGEX INC CENTRAL INDEX KEY: 0000032598 IRS NUMBER: 132620543 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-03794 FILM NUMBER: 161662566 BUSINESS ADDRESS: STREET 1: 44 WALL ST 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 2124954519 MAIL ADDRESS: STREET 1: 44 WALL ST 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10005 FORMER COMPANY: FORMER CONFORMED NAME: EMERGING SECURITIES FUND DATE OF NAME CHANGE: 19770906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DAVIS J MORTON CENTRAL INDEX KEY: 0000900184 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 44 WALL STREET STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10005 SC 13D/A 1 formsc13da.htm DAVIS J MORTON SC 13DA NO 13 5-18-2016 (ENGEX, INC)

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

AMENDMENT NO.  13
SCHEDULE 13D/A

Information to be Included in Statements Filed Pursuant
to Rule 13d-1(a) and Amendments Thereto Filed Pursuant to Rule 13d-2(a)
 
Engex, Inc.
(Name of Issuer)
 
COMMON STOCK, $.10 PAR VALUE
(Title of Class of Securities)
 
292851102 
(CUSIP Number)
 
David Selengut, Esq.
c/o Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
(212) 370-1300
 
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
 
May 18, 2016
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.     
 
Note:  schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7(b) for other parties to whom copies are to be sent.
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


SCHEDULE 13D/A

CUSIP No. 292851102 ____
Page 2 of 6 pages
 
1
NAMES OF REPORTING PERSON
 
 
J. Morton Davis
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS*
 
 
See Item #3 herein
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United States
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
709,869
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
709,869
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
1,093,866
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
67%
 
 
 
 
14
TYPE OF REPORTING PERSON*
 
 
IN
 
 
 
 
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!
 

SCHEDULE 13D/A

CUSIP No. 292851102 ____
Page 3 of 6 pages
 
1
NAMES OF REPORTING PERSON
 
 
Rosalind Davidowitz
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS*
 
 
See Item #3 herein
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United States
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
383,997
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
383,997
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
1,093,866
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
67%
 
 
 
 
14
TYPE OF REPORTING PERSON*
 
 
IN
 
 
 
 
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!
 

SCHEDULE 13D/A

CUSIP No. 292851102 ____
Page 4 of 6 pages
 

1
NAMES OF REPORTING PERSON
 
 
Izor  LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS*
 
 
See Item #3 herein
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
New York
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
167,429
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
167,429
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
167,429
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
10.2%
 
 
 
 
14
TYPE OF REPORTING PERSON*
 
 
CO
 
 
 
 
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!
 

Page 5 of 6 pages
 
J. Morton Davis,  Rosalind  Davidowitz  and Izor LLC ("Izor”), (collectively, the "Reporting Parties") hereby amend the following  Items in their  statement  on Schedule 13D relating to the common stock,  $.10 par value ("shares") of Engex, Inc. (the "Issuer") as follows:

Item 3. is hereby amended by adding the following new paragraph thereto:

Since the previously filed Schedule 13D, Amendment No. 12, Rosalind Davidowitz used her personal funds to purchase 16,036 additional shares.

Item 4. is hereby partially amended as follows:

The purchases were for investment purposes only and not to effect any plan described in (a) - (j) of Item 4.

Item 5. (a) is hereby amended in its entirety as follows:

As of May 18, 2016, Mr. Davis may be deemed to beneficially own 1,093,866 shares (4) or 67% of the Issuer's shares as follows: (i) 58,854 shares owned by D.H. Blair Investment Banking Corp. ("Blair Investment"), (ii) 167,429 shares owned by Izor, (iii) 216,568 shares owned by Rosalind Davidowitz, and (iv) 651,015 shares owned directly by J. Morton Davis.

As of May 18, 2016, Rosalind Davidowitz may be deemed to beneficially own 1,093,866 shares or 67% of the Issuer's shares as indicated in (i) - (iv) above.(5).

As of May 18, 2016, Izor may be deemed to beneficially own 167,429 shares or 10.2% of the Issuer's shares.

(c) Rosalind Davidowitz made the following purchases since the previously filed 13d.
 
Date
 
Purchase/Sale
 
Amount
of Shares
   
Price
 
07/13/2015
 
Purchase
   
100
   
$
4.2495
 
07/13/2015
 
Purchase
   
100
   
$
4.3995
 
11/03/2015
 
Purchase
   
100
   
$
4.31
 
11/03/2015
 
Purchase
   
6,600
   
$
4.35
 
02/05/2016
 
Purchase
   
600
   
$
6.00
 
02/05/2016
 
Purchase
   
100
   
$
6.00
 
02/05/2016
 
Purchase
   
300
   
$
6.00
 
02/17/2016
 
Purchase
   
36
   
$
4.50
 
03/22/2016
 
Purchase
   
200
   
$
4.50
 
03/22/2016
 
Purchase
   
700
   
$
4.50
 
03/22/2016
 
Purchase
   
64
   
$
4.50
 
04/06/2016
 
Purchase
   
100
   
$
4.90
 
04/06/2016
 
Purchase
   
100
   
$
5.20
 
04/06/2016
 
Purchase
   
300
   
$
5.25
 
04/06/2016
 
Purchase
   
100
   
$
5.40
 
04/06/2016
 
Purchase
   
300
   
$
5.40
 
04/06/2076
 
Purchase
   
800
   
$
5.45
 
04/06/2016
 
Purchase
   
900
   
$
4.75
 
04/20/2016
 
Purchase
   
6
   
$
4.50
 
04/20/2016
 
Purchase
   
900
   
$
4.50
 
04/20/2016
 
Purchase
   
94
   
$
4.35
 
05/09/2016
 
Purchase
   
100
   
$
5.25
 
05/09/2016
 
Purchase
   
1,000
   
$
5.35
 
05/10/2016
 
Purchase
   
336
   
$
5.40
 
05/13/2016
 
Purchase
   
100
   
$
5.25
 
05/13/2016
 
Purchase
   
500
   
$
5.36
 
05/16/2016
 
Purchase
   
400
   
$
5.36
 
05/16/2016
 
Purchase
   
900
   
$
5.50
 
05/16/2016
 
Purchase
   
100
   
$
5.50
 
05/16/2016
 
Purchase
   
100
   
$
5.50
 
   
TOTAL
 
16,036 shs
         
 

Page 6 of 6 pages
  
All the purchases were made in the open market.
 


(4)  Although Mr. Davis is including securities owned by Rosalind Davidowitz and Izor in the aggregate amount of shares owned by him, filing of this statement shall not be deemed an admission by J. Morton  Davis that he beneficially owns the securities  attributed  to Rosalind Davidowitz or Izor LLC for any purpose.  J. Morton Davis expressly disclaims beneficial ownership of all securities held by Rosalind Davidowitz and Izor.

(5)  Although Mrs. Davidowitz is including securities owned by J. Morton Davis and Blair Investment in the aggregate amount of shares owned by her, filing of this statement shall not be deemed an admission by Mrs. Davidowitz that she beneficially owns the securities attributed to J. Morton Davis or Blair Investment for any purpose.  Mrs. Davidowitz expressly disclaims beneficial ownership of all securities held by J. Morton Davis and Blair Investment.

SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.

Date:
May 18, 2016
 
 
New York, New York
 
     
 
/s/  J. Morton Davis
 
 
     J. Morton  Davis
 

Date:
May 18, 2016
 
 
New York, New York
 
     
 
/s/ Rosalind Davidowitz
 
 
      Rosalind Davidowitz
 

Date:
May 18, 2016
 
 
New York, New York
 
     
 
Izor LLC
 
     
 
/s/ Rosalind Davidowitz
 
 
     Rosalind Davidowitz
 
 
     Sole Member